Back to Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 4

Very early onset and greater vulnerability in schizophrenia: A clinical and neuroimaging study

Authors Margari F, Presicci A, Petruzzelli MG, Ventura P, Di Cuonzo F, Palma M, Margari L

Published 8 August 2008 Volume 2008:4(4) Pages 825—830

DOI https://doi.org/10.2147/NDT.S2484



Francesco Margari1, Anna Presicci2, Maria Giuseppina Petruzzelli1, Patrizia Ventura2, Franca Di Cuonzo3, Michele Palma3, Lucia Margari2

1Department of Neurologic and Psychiatry Sciences, Psychiatry Unit; 2Department of Neurologic and Psychiatry Sciences, Child Neuropsychiatry Unit; 3Department of Neurologic and Psychiatry Sciences, Neuroradiologic Unit, University of Bari, Italy

Abstract: Although schizophrenia has been diagnosed in children, this group of disorders has received too little attention in the clinical and research literature. Preliminary data suggest that early onset schizophrenia (EOS) and very early onset schizophrenia (VEOS) tend to have a worse outcome than adult onset schizophrenia, and seem to be related to a greater familial vulnerability, due to genetic, psychosocial, and environmental factors. Recently, advanced neuroimaging techniques have revealed structural and functional brain abnormalities in some cerebral areas. This paper reports on a case diagnosed as VEOS, with premorbid year-long psychopathological history. The patient showed atypical proton magnetic resonance spectroscopy findings, and normal brain and spine computer tomography and brain magnetic resonance images.

Keywords: very early onset schizophrenia, early onset schizophrenia, premorbid neurodevelopmental abnormalities, magnetic resonance spectroscopy

Creative Commons License © 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.